West Pharmaceutical Services | WST - Creditori Commerciali

Prezzo Delle Azioni
301.95
Cambio Giornaliero
-4.21 -1.38%
Mensile
22.24%
Annuale
40.74%
Q2 Previsione
299.61




Creditori Commerciali Cambiamento Data
Align Technology USD 121.45M 4.1M 2025-12
Avanos Medical USD 55.5M 1.3M 2025-12
Baxter International USD 999M 46M 2025-12
Becton, Dickinson and Co. USD 6.14B 4.16B 2025-12
Cerus USD 25.47M 5.05M 2025-09
Charles River Laboratories USD 148.8M 20.82M 2025-12
Cooper Companies USD 225.8M 74.6M 2025-12
Dentsply International USD 300M 32M 2025-12
Haemonetics USD 48.69M 13M 2025-12
ICU Medical USD 154.37M 17.38M 2025-12
Insulet USD 75M 26.8M 2025-12
Integra LifeSciences USD 95.73M 3.42M 2025-12
IQVIA Holdings USD 3.75B 201M 2025-12
J&J USD 10.46B 1.53B 2026-03
Medtronic USD 2.57B 12M 2025-12
Merit Medical Systems USD 60.55M 4.19M 2025-12
Neogen USD 75.2M 12.16M 2025-12
OraSure Technologies USD 6.52M 161K 2025-12
Quidel USD 279.4M 65.7M 2025-12
Repligen USD 30.01M 584K 2025-12
Rockwell Medical USD 1.5M 423K 2025-06
Solventum Corp USD 687M 18M 2025-12
STAAR Surgical USD 11.57M 2.39M 2025-12
Terumo JPY 97.49B 4.46B 2025-12
Utah Medical Products USD 911K 143K 2025-12
West Pharmaceutical Services USD 252.3M 1.4M 2026-03